Get started
Author

Ling Cheng

Risankizumab for Ulcerative Colitis
2024 · Edouard Louis, Stefan Schreiber, et al. · JAMA · 134
PDF
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial
2024 · Joan T. Merrill, Yoshiya Tanaka, et al. · Arthritis & Rheumatology · 65
Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis
2019 · Amit Khatri, Doerthe Eckert, et al. · The Journal of Clinical Pharmacology · 33
PDF
Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque Psoriasis
2018 · Amit Khatri, Ling Cheng, et al. · Clinical Pharmacokinetics · 28
PDF
Factors Associated With Willingness to Try Different Pain Treatments for Pain After a Spinal Cord Injury
2003 · Jennifer A. Haythornthwaite, Stephen Wegener, et al. · Clinical Journal of Pain · 23
[Vertigo and dizziness].
2007 · Yiu-Tong Chu, Ling Cheng · PubMed · 15
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies
2025 · Remo Panaccione, Edouard Louis, et al. · Journal of Crohn s and Colitis · 14
PDF
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension study
2025 · Joan T Merrill, Amit Saxena, et al. · RMD Open · 12
PDF
Environmental chemical exposures and a machine learning-based model for predicting hypertension in NHANES 2003–2016
2024 · Kun Guo, Weicheng Ni, et al. · BMC Cardiovascular Disorders · 11
PDF
Pharmacokinetic Comparability of Risankizumab Formulations in Prefilled Syringe and Auto-injector for Subcutaneous Injection
2021 · Hoi-Kei Lon, Ling Cheng, et al. · Clinical Therapeutics · 11
PDF
904 Additional Risankizumab Therapy Is Effective in Patients With Moderately to Severely Active Ulcerative Colitis Who Did Not Achieve Clinical Response to Initial 12-week Induction Therapy: an Analysis of Phase 3 Inspire and Command Studies
2024 · Remo Panaccione, Gil Melmed, et al. · Gastroenterology · 2
984 Risankizumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 Command Study
2024 · Stefan Schreiber, Remo Panaccione, et al. · Gastroenterology · 2
PT4:01 Achievement of treat to target measures with upadacitinib in patients with systemic lupus erythematosus: phase 2 randomized SLEek clinical trial results
2026 · Eric F Morand, Joan T Merrill, et al.
PDF
Impact of Extended Risankizumab Treatment in Patients With Ulcerative Colitis Who Did Not Respond to Induction Treatment
2025 · Remo Panaccione, Gil Y. Melmed, et al. · Clinical Gastroenterology and Hepatology
Improvements in BILAG Musculoskeletal and Mucocutaneous Domains at Week 48 in a Phase 2 Double-Blind Placebo-Controlled Trial of ABBV-599 (Elsubrutinib + Upadacitinib Combination) and Upadacitinib Monotherapy for Treatment of Moderately to Severely Active Systemic Lupus Erythematosus
2025 · Zahi Touma, Amit Saxena, et al. · The Journal of Rheumatology
Efficacy and Safety of Elsubrutinib and Upadacitinib Combination and Upadacitinib Monotherapy for the Treatment of Systemic Lupus Erythematosus: Results Through 104 Weeks
2025 · Kristin D’Silva, Joan Merrill, et al. · The Journal of Rheumatology
S1472 Efficacy of Risankizumab Maintenance Therapy by Clinical Remission and Endoscopic Improvement Status in Patients With Moderately to Severely Active Ulcerative Colitis: Post Hoc Analysis of the COMMAND Phase 3 Study
2024 · Remo Panaccione, Peter Bossuyt, et al. · The American Journal of Gastroenterology
Su1792 EFFICACY OUTCOMES OF PLACEBO MAINTENANCE TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RESPONDED TO PLACEBO INDUCTION THERAPY: RESULTS FROM THE PHASE 3 COMMAND STUDY
2024 · Raja Atreya, Marc Ferrante, et al. · Gastroenterology
Influence of stir-baked with sand on active ingredients, diarrhea and hepatoprotection of Herpetospermum caudigerum
2015 · Juan-juan Li, Gang Shen, et al. · China Journal of Chinese Materia Medica
Reliability and validity of Chinese-version of the chronic pain acceptance questionnaire-8
2014 · Cheng Xin, Hongyan Wang, et al. · Zhonghua xingwei yixue yu naokexue zazhi
Works count: 20
Citation count: 350
H-index: 10
I10-index: 10
Year
Topic
Type